CNS Neuroscience & Therapeutics · 2022 · 18 citations · 64 references
MedicineNeurological SurgeryNeurologyClinical NeuroscienceFunctional NeurosurgeryNeuropsychiatryDeep Brain StimulationEssential Tremor SurgeryMovement Disorder SurgeryNeurophysiology Of Movement DisordersNeurostimulationTremor DisordersComparative Clinical TrialsDeep Brain Stimulation EffectsEssential TremorPosterior Subthalamic Area TargetingPubmed SearchSurgical Treatment Of TremorVentral Intermediate Nucleus StimulationVentral Intermediate Nucleus Targeting
BACKGROUND/AIMS: The efficacy and safety of posterior subthalamic area (PSA) and ventral intermediate nucleus (VIM) deep brain stimulation (DBS) in the treatment of essential tremor (ET) have not been compared in large-scale studies. We conducted a secondary analysis to identify the superior target of ET-DBS treatment. METHODS: PubMed, Embase, Cochrane Library, and Google Scholar were searched for relevant studies before September 2021. The tremor-suppression efficacy and rate of stimulation-related complications (SRCR) after PSA-DBS and VIM-DBS treating ET were quantitatively compared. Secondary outcomes, including tremor subitem scores and quality of life results, were also analyzed. Subgroup analyses were further conducted to stratify by follow-up (FU) periods and stimulation lateralities. This study was registered in Open Science Framework (DOI: 10.17605/OSF.IO/7VJQ8). RESULTS: A total of 23 studies including 122 PSA-DBS patients and 326 VIM-DBS patients were analyzed. The average follow-up time was 12.81 and 14.66 months, respectively. For the percentage improvement of total tremor rating scale (TRS) scores, PSA-DBS was significantly higher, when compared to VIM-DBS in the sensitivity analysis (p = 0.030) and main analysis (p = 0.043). The SRCR after VIM-DBS was higher than that of PSA-DBS (p = 0.022), and bilateral PSA-DBS was significantly superior to both bilateral and unilateral VIM-DBS (p = 0.001). CONCLUSIONS: This study provided level IIIa evidence that PSA-DBS was more effective and safer for ET than VIM-DBS in 12-24 months, although both PSA-DBS and VIM-DBS were effective in suppressing tremor in ET patients. Further prospective large-scale randomized clinical trials are warranted in the future.
64
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
David Moher, A. Liberati, Jennifer Tetzlaff et al. · BMJ · 2009 · 83.3K citations · Full text
Maarten Bot, Pepijn van den Munckhof, Roy A.E. Bakay et al. · Stereotactic and Functional Neurosurgery · 2017 · 672 citations · Full text
Medicine, Neurosurgery, Surgery +13
Thalamic and Subthalamic Deep Brain Stimulation for Essential Tremor
Ulrika Sandvik, Lars‐Owe Koskinen, Anders Lundquist et al. · Neurosurgery · 2011 · 291 citations
Medicine, Neuroscience, Neurosurgery +16
Wery P. M. van den Wildenberg, G.J.M. van Boxtel, Maurits W. van der Molen et al. · Journal of Cognitive Neuroscience · 2006 · 266 citations · Full text